Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 61 (RNA5SP61) is a member of the 5S ribosomal RNA pseudogene family in humans. Pseudogenes are non-functional sequences similar to known genes but lack protein-coding or well-defined regulatory activity. The 5S ribosomal RNA is a component of the large ribosomal subunit and is vital for ribosome structure and function in translation, but pseudogene copies like RNA5SP61 do not encode functional rRNA and are generally not transcribed into functional RNAs. Some 5S rRNA pseudogene transcripts in humans have been found to interact with innate immune sensors such as RIG-I under specific conditions (e.g., viral infection), but this has not been demonstrated for RNA5SP61 itself—rather for distantly related pseudogenes like RNA5SP141. There is no evidence that RNA5SP61 participates in cellular signaling, pharmacological mechanisms, or has clinical relevance as a biomarker or therapeutic target. RNA5SP61 is not considered a molecular target for drug development, nor is it associated with disease pathology or therapeutic modulation. RNA5SP61 is a pseudogene—not a gene product, protein, or regulatory molecule with defined functional or therapeutic relevance. Pseudogenes can sometimes regulate parent gene expression via competing endogenous RNA mechanisms (ceRNA) or generation of small interfering RNAs, but there is no evidence of such a function for RNA5SP61 specifically. No drugs, mechanisms of action, biomarker roles, or safety concerns are associated with RNA5SP61. It is not a therapeutic target and should generally be excluded from structured target/therapeutic databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 61 (RNA5SP61).